Efficacy and safety of camrelizumab combined with chemotherapy as second-line treatment for locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma by Yinfang Gu, Xiaofang Zou, Junlin Zhu, Guowu Wu

Subjects: “…Camrelizumab…”
Get full text

Camrelizumab-induced immune-related toxic epidermal necrolysis in lung adenocarcinoma: a case report and literature review by Man Sun, Huan Zhou, Dan Zang, Chen-Guang Liu, Jun Chen

Subjects: Get full text